New dosage form: Mounjaro KwikPen Get the info you need on this new dosage form, part of our drug news roundup for April. Once-weekly insulin: a spotlight on insulin icodecPatients using icodec tend to have a higher incidence of hypoglycemic events compared to glargine or degludec, especially on days 2–4 of the weekly dosing cycle. Is chocolate really an ally in diminishing the risk of type 2 diabetes? Research suggests bioactive compounds in chocolate may help reduce the risk of type 2 diabetes. But not all chocolate offers the same benefits. POP QUIZ: Diabetes regimen simplification for older adults Experts from the International Geriatric Diabetes Society recently developed the ‘4S Pathway.’ New study examines whether GLP-1 RAs cause postoperative aspiration pneumonia Large cohort study finds patients taking GLP-1 RAs undergoing common surgical procedures have no increased risk of postoperative aspiration pneumonia. A painless patch? A potential new option for diabetes monitoring Researchers at the University of Waterloo are close to commercializing these next-generation monitoring tool. Could an Ozempic-like medication soon be just another plant grown in your garden? Students at the University of Ottawa launch biomanufacturing platform to produce diabetes drugs. Would a one-hour vs. two-hour wait really get more new moms to test for diabetes? This researcher thinks so The postpartum period is a great time to check in with women who had gestational diabetes, according to this UofT medicine professor. Diabetes regimen simplification and deprescribing strategies in older adults Researchers introduce the “4S Pathway” to help manage diabetes regimens in older individuals experiencing difficulties with their current glycemic management approach. The rising star of GLP-1 receptor agonists: Keeping up with the cardiovascular outcomes Glucagon-like peptide-1 receptor agonists have gone Hollywood. 1 2 3 4 5 Next Last
